Preconditioning with L-Ala-Gln reduces the expression of inflammatory markers (TNF-α, NF-κB, IL-6 and HO-1) in an injury animal model of cerebrovascular ischemia in Meriones unguic... by Leidelamar Rosário Alves de Oliveira (10394107)

“…Conclusion These findings suggest a protective effect of L-Ala-Gln by decreasing levels of TNF-alpha, IL-6 and NF-κB and Increasing levels of HO-1.…”

Data Sheet 1_Beat-to-beat coronary wave intensity analysis: implications of backward waves originating from microvascular.docx by Xinzhou Xie (587158)

“…Compared to rest, adenosine-induced hyperemia significantly increased cBCW (1.88 ± 1.46 ×10⁴ W/m²s vs. 2.31 ± 1.74 × 10⁴ W/m²s, p < 0.001) and peak backward compression wave intensity (pBCW) (4.30 ± 4.61 ×10⁵ W/m²s² vs. 5.21 ± 4.68 × 10⁵ W/m²s², p = 0.008), while significantly decreasing peak backward decompression wave intensity (pBDW) (5.41 ± 6.06 × 10⁵ W/m²s² vs. 3.99 ± 4.64 × 10⁵ W/m²s², p < 0.001), with no significant effect on cBDW. …”

Albumin Kinetics in Patients Undergoing Major Abdominal Surgery by Åke Norberg (561515)

“…TER was unchanged, 4.9 (3.1, 6.8) %/hour versus 5.5 (3.9, 7.2) (p = 0.63). Plasma volume was unchanged but plasma albumin decreased from 33.5 (30.9, 36.2) to 22.1 (19.8, 24.3) g/L. …”

Data_Sheet_1_Comprehensive survey of transposon mPing insertion sites and transcriptome analysis for identifying candidate genes controlling high protein content of rice.DOCX by Yuki Monden (12259496)

“…We detected two rice lines harboring a significantly higher protein content (namely, HP5-7 and HP7-5) in the EG4 population. …”

Table_1_Comprehensive survey of transposon mPing insertion sites and transcriptome analysis for identifying candidate genes controlling high protein content of rice.XLSX by Yuki Monden (12259496)

“…We detected two rice lines harboring a significantly higher protein content (namely, HP5-7 and HP7-5) in the EG4 population. …”

Table 9_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 1_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 2_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 10_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 3_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 8_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 6_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 4_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Table 7_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

“…Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”

Model-based prediction of performance for different levels of external stimulation. by Laura Dempere-Marco (139148)

“…<b>A</b> Performance calculated as (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0042719#pone.0042719.e303" target="_blank">Eq. 7</a>), and <b>B</b> performance calculated as (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0042719#pone.0042719.e305" target="_blank">Eq. 8</a>). …”

Model-based prediction of performance for different levels of saliency. by Laura Dempere-Marco (139148)

“…<b>A</b> Performance calculated as (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0042719#pone.0042719.e303" target="_blank">Eq. 7</a>), and <b>B</b> performance calculated as (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0042719#pone.0042719.e305" target="_blank">Eq. 8</a>). …”

Inhibitory effect of IgG on ApoCell-phagocytosis. by Menelaos N. Manoussakis (661354)

“…Similar results were obtained by slightly different experimental setups assaying the ingestion of CFSE-labelled IgG-pretreated apoptotic cells by electronically gated CD14-stained MDM in dual-color flow cytometry (<b>C</b>; representative results from 3 independent experiments) or the uptake of pHrodo-SE-labelled apoptotic cells in single-color flow cytometry (<b>D</b>). <b>E</b>. Highly significant inverse correlation between the rates of ApoCell-phagocytosis obtained by the various purified serum IgG preparations used (shown in A) and the levels of anti-ApoCell antibodies in those preparations (shown in A).…”

WARP expression pattern in the heart. by Sophie Deckx (800206)

“…Images of the original unadjusted blots are provided in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139199#pone.0139199.s001" target="_blank">S1 Fig</a> (d and e) Confocal microscopy confirmed the co-localization of WARP with perlecan in the uninfarcted heart, showing a network of WARP and perlecan as a honeycomb-structure surrounding the cardiomyocytes. …”

Normal Proliferation and Tumorigenesis but Impaired Pancreatic Function in Mice Lacking the Cell Cycle Regulator Sei1 by Pablo J. Fernandez-Marcos (254689)

“…<div><p>Sei1 is a positive regulator of proliferation that promotes the assembly of Cdk4-cyclin D complexes and enhances the transcriptional activity of E2f1. …”

Supplementary Material for: Headache in Pediatric Moyamoya Disease after Revascularization Surgery by Yang J. (3341234)

“…Headache disturbed daily life in 12 (18.5%) patients. Among the 32 (35.6%) patients who suffered headache during both the pre- and postoperative period, the headache quality was similar in 27 (84.4%) patients, and its severity decreased in 24 (75.0%) and did not change in 8 (25.0%) patients. …”